A survey of telomerase activity in human cancer, European Journal of Cancer, vol.33, issue.5, pp.787-91, 1990. ,
DOI : 10.1016/S0959-8049(97)00062-2
Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-74, 2011. ,
DOI : 10.1016/j.cell.2011.02.013
Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer, Genes, Chromosomes and Cancer, vol.13, issue.12, pp.1098-109, 2008. ,
DOI : 10.1111/j.1349-7006.2002.tb02166.x
Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome, Breast Cancer Research, vol.24, issue.3, p.56, 2011. ,
DOI : 10.1186/1471-2407-6-206
URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2893?site=breast-cancer-research.biomedcentral.com
ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis, The Journal of Pathology: Clinical Research, vol.7, issue.Suppl 1, pp.234-280, 2016. ,
DOI : 10.1371/journal.pone.0048670
URL : https://doi.org/10.1002/cjp2.52
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications, Genes, vol.6, issue.7, 2016. ,
DOI : 10.1371/journal.pone.0052989
URL : http://www.mdpi.com/2073-4425/7/7/38/pdf
Direct activation of TERT transcription by c-MYC, Nat Genet, vol.21, pp.220-224, 1999. ,
Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells, Cancer Science, vol.24, issue.6, pp.1092-1101, 2008. ,
DOI : 10.1128/MCB.19.6.3989
Telomerase activation, cellular immortalization and cancer, Annals of Medicine, vol.18, issue.2, pp.123-132, 2001. ,
DOI : 10.1038/71894
Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene, Protein & Cell, vol.67, issue.1, pp.22-32, 2010. ,
DOI : 10.1158/0008-5472.CAN-06-3396
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal, Proceedings of the National Academy of Sciences, vol.360, issue.8 ,
DOI : 10.1056/NEJMoa0808710
Frequency of TERT promoter mutations in human cancers, Nature Communications, vol.30, p.2185, 2013. ,
DOI : 10.1038/onc.2010.512
Highly Recurrent TERT Promoter Mutations in Human Melanoma, Science, vol.38, issue.5, pp.957-966, 2013. ,
DOI : 10.1038/ng1777
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423787/pdf
Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter ??? effect on telomerase expression and telomere length maintenance in non-small cell lung cancer, European Journal of Cancer, vol.42, issue.10, pp.1466-74, 1990. ,
DOI : 10.1016/j.ejca.2006.02.014
Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc, Journal of Biological Chemistry, vol.58, issue.35, pp.23567-80, 2008. ,
DOI : 10.1016/j.ejca.2006.02.014
URL : http://www.jbc.org/content/283/35/23567.full.pdf
Expression level of <i>hTERT</i> is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma, Oncotarget, vol.5, issue.10, pp.3399-407, 1975. ,
DOI : 10.18632/oncotarget.1975
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact, Annals of Oncology, vol.25, issue.8 ,
DOI : 10.1093/annonc/mdu183
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer, International Journal of Cancer, vol.24, issue.8, pp.2274-80, 2016. ,
DOI : 10.1016/j.cytogfr.2013.01.005
Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay, Clin Cancer Res Off J Am Assoc Cancer Res, vol.6, pp.452-461, 2000. ,
The Somatic Genomic Landscape of Glioblastoma, Cell, vol.155, issue.2, pp.462-77, 2013. ,
DOI : 10.1016/j.cell.2013.09.034
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations, British Journal of Cancer, vol.5, issue.10, pp.2024-2056, 2014. ,
DOI : 10.1007/s13238-010-0014-1
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism, Proceedings of the National Academy of Sciences, vol.84, issue.11, pp.17426-17457, 2013. ,
DOI : 10.1054/bjoc.2001.1823
The <i>TERT</i> promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer, Oncotarget, vol.7, issue.1, pp.684-99, 2016. ,
DOI : 10.18632/oncotarget.6331
Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer ,
DOI : 10.1002/ijc.29526
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.29526/pdf
promoter mutations in clear cell renal cell carcinoma, International Journal of Cancer, vol.103, issue.10, pp.2448-52, 2015. ,
DOI : 10.1073/pnas.0510085103
<i>TERT</i> promoter mutations and polymorphisms as prognostic factors in primary glioblastoma, Oncotarget, vol.6, issue.18, pp.16663-73, 2015. ,
DOI : 10.18632/oncotarget.4389
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=4389&path%5B%5D=12478
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis, Oncotarget, vol.6, issue.28, pp.25109-25129, 2015. ,
DOI : 10.18632/oncotarget.4668
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=4668&path%5B%5D=12873
Frequent amplification of the telomerase reverse transcriptase gene in human tumors, Cancer Res, vol.60, pp.6230-6235, 2000. ,
<i>TERT</i> promoter mutations and gene amplification: Promoting <i>TERT</i> expression in Merkel cell carcinoma, Oncotarget, vol.5, issue.20, pp.10048-57, 2014. ,
DOI : 10.18632/oncotarget.2491
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=2491&path%5B%5D=4450
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer, British Journal of Cancer, vol.10, issue.10, pp.1452-1461, 2006. ,
DOI : 10.1158/1078-0432.CCR-03-0470
) gene in cervical carcinomas, Genes, Chromosomes and Cancer, vol.92, issue.3, pp.269-75, 2002. ,
DOI : 10.1093/jnci/92.9.690
hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer, International Journal of Cancer, vol.104, issue.3, pp.395-400, 2005. ,
DOI : 10.1016/0016-5085(93)90368-M
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.21020/pdf
TERT gene amplification is associated with poor outcome in acral lentiginous melanoma, Journal of the American Academy of Dermatology, vol.71, issue.4, pp.839-880, 2014. ,
DOI : 10.1016/j.jaad.2014.05.035
Novel anticancer therapeutics targeting telomerase, Cancer Treatment Reviews, vol.39, issue.5, pp.444-56, 2013. ,
DOI : 10.1016/j.ctrv.2012.06.007
htert expression correlates withMYC over-expression in human prostate cancer, International Journal of Cancer, vol.21, issue.2, pp.172-178, 2000. ,
DOI : 10.1002/(SICI)1097-0215(20000320)89:2<172::AID-IJC12>3.0.CO;2-8
Myc activates telomerase, Genes & Development, vol.12, issue.12, pp.1769-74, 1998. ,
DOI : 10.1101/gad.12.12.1769
URL : http://genesdev.cshlp.org/content/12/12/1769.full.pdf
Transcriptional Regulation of Telomerase Activity: Roles of the the Ets Transcription Factor Family, Annals of the New York Academy of Sciences, vol.42, issue.1, pp.36-47, 2007. ,
DOI : 10.1016/S0014-4800(03)00092-3
Transforming Growth Factor ?? Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT Gene, Journal of Biological Chemistry, vol.19, issue.35, pp.25588-600, 2006. ,
DOI : 10.1016/S0092-8674(02)00801-2
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity, Journal of Clinical Investigation, vol.125, issue.5, pp.2109-2131, 2015. ,
DOI : 10.1172/JCI79134DS1
URL : http://www.jci.org/articles/view/79134/files/pdf
A Shared Docking Motif in TRF1 and TRF2 Used for Differential Recruitment of Telomeric Proteins, Science, vol.64, issue.11, pp.1092-1098, 2008. ,
DOI : 10.1158/0008-5472.CAN-04-0136
MYC and Metastasis, Cancer Research, vol.71, issue.6, pp.2034-2041, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-3776
URL : http://cancerres.aacrjournals.org/content/canres/71/6/2034.full.pdf
MYC regulation of a "poor-prognosis" metastatic cancer cell state, Proceedings of the National Academy of Sciences, vol.30, issue.3, pp.3698-703, 2010. ,
DOI : 10.1016/S1046-2023(03)00032-X
Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer, Human Pathology, vol.39, issue.8, pp.1221-1229, 2008. ,
DOI : 10.1016/j.humpath.2007.11.019
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia, Blood, vol.111, issue.4, pp.2388-91, 2008. ,
DOI : 10.1182/blood-2007-09-111245
URL : https://hal.archives-ouvertes.fr/ensl-00781642
Telomeres and chromosomal instability in chronic lymphocytic leukemia, Leukemia, vol.27, issue.2, pp.490-493, 2013. ,
DOI : 10.1016/j.ejca.2008.11.014
Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel, International Journal of Cancer, vol.342, issue.2, pp.162-71, 2001. ,
DOI : 10.1056/NEJM200002243420801
Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis, Journal of Medical Genetics, vol.41, issue.11, p.118, 2004. ,
DOI : 10.1136/jmg.2004.022400
An atypical 0.8??Mb inherited duplication of 22q11.2 associated with psychomotor impairment, European Journal of Medical Genetics, vol.55, issue.11, pp.650-655, 2012. ,
DOI : 10.1016/j.ejmg.2012.06.014